# Vulvovaginal Candidiasis:  Developing Drugs for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/vulvovaginal-candidiasis-developing-drugs-for-treatment/3c14a50c-15d0-4ad3-94ec-76a32afa2bdb

> FDA guidance document: Vulvovaginal Candidiasis:  Developing Drugs for Treatment. Issue date: August 01, 2019. Get complete insights and analysis.

---

## Details

- Title: Vulvovaginal Candidiasis:  Developing Drugs for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-08-01
- Last Changed: 2020-05-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-1662">FDA-2016-D-1662</a>

## Related Documents

- [Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/smallpox-variola-virus-infection-developing-drugs-for-treatment-or-prevention-guidance-for-industry/c6eb4d8b-888a-4dc5-bb4d-877f66f968fb)
- [Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/uncomplicated-urinary-tract-infections-developing-drugs-for-treatment-guidance-for-industry/c70a4ac7-4c57-4214-9174-25145ed55675)
- [Osteoporosis:  Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/osteoporosis-nonclinical-evaluation-of-drugs-intended-for-treatment-guidance-for-industry-guidance-for-industry/8305ef9e-7edf-412b-bb46-28ef3a7f9493)